Family Medicine pharmacology Flashcards
formoterol
(family/mechanism/indications)
long-acting β-agonists
bronchial smooth muscle relaxation (increased cAMP via adenylate cyclase activation)
step-up from low- or medium-dose inhaled corticosteroid (avoid as monotherapy)
lisinopril
(side effects/contraindications)
dry cough
angioedema
hyperkalemia
elevated creatinine
avoid in pregnancy and in patients with bilateral RAS
less effective in African-Americans
spironolactone
(side effects/contraindications)
antiandrogenic effects (gynecomastia, ED, impaired libido)
hyperkalemia (esp. in conjunction with ACEIs)
contraindicated in Addison’s disease, renal impairment/insufficiency
canagliflozin
(side effects/contraindications)
UTIs, yeast infections
hyperkalemia
volume depletion/dehydration
possible association with bladder cancer (dapagliflozin)
contraindicated in renal failure
ezetimibe
(side effects/contraindications)
diarrhea
cough/upper respiratory symptoms
elevated LFTs (potentiates statin effects)
albuterol
(family/mechanism/indications)
short-acting β-agonists
bronchial smooth muscle relaxation (increased cAMP via adenylate cyclase activation)
first-line rescue medication for attacks and EIB
pioglitazone
(family/mechanism/indications)
thiazolidinediones
increase peripheral insulin sensitivity by activation of PPARγ
cromolyn sodium
(side effects/contraindications)
unpleasant taste
inconvenient (q.i.d.) initial dosing schedule
theophylline
(family/mechanism/indications)
methylxanthines
bronchial smooth muscle relaxation (increase cAMP by blocking cAMP PDE)
step-up/add-on in patients failing other therapies
metoprolol
(side effects/contraindications)
fatigue
bradycardia (avoid in bradycardic pts)
bronchospasm (avoid in asthma or COPD)
reduced peripheral circulation
reduced exercise tolerance
“rebound” effect with abrupt withdrawal
masks effects of hypoglycemia (use caution in DM)
fluticasone
beclomethasone
budesonide
(family/mechanism/indications)
inhaled corticosteroids
reduction of inflammation and airway hyperresponsiveness
first-line medication for long-term control
nifedipine
(side effects/contraindications)
edema, CHF exacerbation
headache
flushing
gingival hyperplasia
use caution in post-MI, CHF, or in conjunction with β-blockers
cholestyramine
(family/mechanism/indications)
bile acid sequestrants
acts as peripheral “sink” for bile acids, causing knock-on increase in LDL uptake by liver
adjunct therapy to statins, esp. for elevated LDL
acarbose
(family/mechanism/indications)
α-glucosidase inhibitors
block intestinal glucose uptake at brush border
taken with meals; useful in near-goal patients with elevated postprandial glucose
hydrochlorothiazide
(family/mechanism/indications)
thiazide diuretic
disuresis/volume depletion; possible reduction in PVR
standard first-line treatment in essential hypertension
“compelling indications”: CHF, CVD risk, DM, stroke
acarbose
(side effects/contraindications)
flatulence, diarrhea
abdominal pain
possible risk of fulminant hepatitis
can cause hypoglycemia with secretagogues (treat with dextrose, not sucrose)
contraindicated in cirrhosis, IBD, intestinal obstruction, malabsorption
ezetimibe
(family/mechanism/indications)
2-azetidinones
blocks sterol transporter at intestinal brush border, impairing cholesterol uptake
exact role unclear; can be used in patients failing other therapies or as dose-sparing therapy with statins
repaglinide
(side effects/contraindications)
hypoglycemia
weight gain
avoid in pts with high risk of hypoglycemia (elderly, frail, acutely ill)
cromolyn sodium
(mechanism/family/indications)
mast cell stabilizers
alternative to ICS for maintenance therapy
sitagliptin
(family/mechanism/indications)
DPP-4 inhibitors
block degradation of GLP-1 by DPP-4, increasing GLP-1 levels (and promoting incretin effect)
nifedipine
(family/mechanism/indications)
dihydropyridine calcium channel blocker
reduced cardiac contractility and PVR (via vascular smooth muscle relaxation) - non-DHPs more cardioselective
“compelling indications”: CVD risk, DM
useful in angina
doxazosin
(side effects/contraindications)
orthostatic hypotension
syncope (first-dose or in conjunction with PDE5 inhibitor)
fatigue
avoid as monotherapy for HTN
ipratropium
(family/mechanism/indications)
anticholinergics
block smooth muscle contraction (by blocking muscarinic cholinergic receptors)
adjunct to albuterol for acute treatment
fluticasone
beclomethasone
budesonide
(side effects/contraindications)
candidiasis
irritation/epistaxis
growth impairment
steroid effects: immunosuppression, edema/hypertension, hyperglycemia, osteoporosis, adrenal suppression, catacaract/glaucoma